[Detection of JAK2V617F mutation and its clinical significance in 80 patients with M2 acute myelogenous leukemia].

Shen, Yi-min; Chao, Hong-ying; Zhang, Ri; Li, Wei-yang; Feng, Yu-feng; Zhu, Zi-ling; Xue, Yong-quan

Shen, Yi-min; Chao, Hong-ying; Zhang, Ri; Li, Wei-yang; Feng, Yu-feng; Zhu, Zi-ling; Xue, Yong-quan.

Affiliation

Shen YM; Department of Hematology, First Affiliated Hospital of Soochow University, Jiangsu Insititute of Hematology, Suzhou 215006, China. symsjx@sohu.com

Zhonghua Zhong Liu Za Zhi ; 31(5): 366-70, 2009 May.

Article in Zh | MEDLINE | ID: mdl-19799086

Subject(s)

Janus Kinase 2/genetics; Leukemia, Myeloid, Acute/genetics; Mutation; Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/therapeutic use; DNA Mutational Analysis; DNA, Neoplasm/genetics; Female; Follow-Up Studies; Humans; Leukemia, Myeloid, Acute/drug therapy; Male; Middle Aged; Remission Induction; Survival Rate; Young Adult

Search on Google

XML

PubMed Links

Database: MEDLINE Main subject: Leukemia, Myeloid, Acute / Janus Kinase 2 / Mutation Type of study: Diagnostic_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Language: Zh Year: 2009 Type: Article

Search on Google

XML

PubMed Links